以质量求发展，以服务铸品牌

Journal of Nursing ›› 2020, Vol. 27 ›› Issue (14): 68-70.doi: 10.16460/j.issn1008-9969.2020.14.068

Previous Articles     Next Articles

  

  • Received:2019-12-14 Online:2020-07-25 Published:2020-08-11

PDF (PC)

339

Like

CLC Number: 

  • R473.73
[1] 杨何,张升,辛艳飞. 肿瘤免疫治疗研究进展[J]. 中国临床药理学与治疗学,2016,21(9):1074-1080.
[2] Moslehi JJ, Salem JE, Sosman JA, et al.Increased Reporting of Fatal Immune Checkpoint Inhibitor-associated Myocarditis[J]. Lancet Oncol, 2018, 391(10124):933.
[3] Brahmer JR, Lacchetti C, Thompson JA.Management of Immune-related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary[J]. J Clin Oncol,2018 ,14(4):247-249.
[4] Gettinger SN, Horn L,Gandhi L,et al.Overall Survival and Long-term Safety of Nivolumab (Anti-programmed Death 1 Antibody,BMS-936558,ONO-4538) in Patients with Previously Treated Advanced Non-small-cell Lung Cancer[J]. J Clin Oncol,2015,33(18):2004-12.
[5] Puzanov I, Diab A, Abdallah K, et al.Managing Toxicities Associated with Immune Checkpoint Inhibitors: Consensus Recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group[J]. J Immunotherapy Cancer,2017,5(1):95.
[6] Leonardi GC, Gainor JF, Altan M, et al.Safety of Programmed Death-1 Pathway Inhibitors among Patients with Non-small-cell Lung Cancer and Preexisting Autoimmune Disorders[J]. J Clin Oncol,2018,36(19):1905-1912.
[7] Khoja L, Day D, Wei-Wu Chen T, et al. Tumour-and Class-specific Patterns of Immune-related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review[J]. Ann Oncol,2017,28(10):2377-2385.
[8] Spain L, Walls G, Julve M, et al.Neurotoxicity from Immune-checkpoint Inhibition in the Treatment of Melanoma: A Single Centre Experience and Review of the Literature[J]. Ann Oncol, 2017, 28(2):377-385.
[9] Zimmer L, Goldinger SM, Hofmann L, et al.Neurological,Respiratory, Musculoskeletal, Cardiac and Ocular Side-effects of Anti-PD-1 Therapy[J]. Eur J Cancer, 2016, 60: 210-225.
[10] 郭潇潇,王汉萍,周佳鑫,等. 免疫检查点抑制剂相关心脏不良反应的临床诊治建议[J]. 中国肺癌杂志,2019,22(10):627-632.
[11] Champiat S, Lambotte O, Barreau E, et al.Management of Immune Checkpoint Blockade Dysimmune Toxicities:A Collaborative Position Paper[J]. Ann Oncol, 2016,27(4):559-574.
[12] 王雅坤,张小田. 免疫检查点抑制剂的毒性风险分析[J]. 临床肿瘤学杂志,2017,22(8):735-741.
[1] CHEN Wei-juan, ZHAO Hai-yan, KONG Dong, CUI Xin, YANG Li-juan. Evidence Summary of Screening and Assessment of Cancer-related Fatigue in Adult Cancer Patients [J]. Journal of Nursing, 2020, 27(14): 20-25.
[2] JIANG Li-ling, WANG Jian-ning, LI Li-qun, ZHANG Shu, GONG Jing-jing, ZHU Huan-huan, DONG Ting-ting. Correlation between Health Literacy and Fear of Cancer Recurrence in Female Breast Cancer Patients: A 110-case Study [J]. Journal of Nursing, 2020, 27(14): 26-29.
[3] . [J]. Journal of Nursing, 2020, 27(12): 10-13.
[4] ZHU Yi-fan, CHEN Zhi-qian, GUO Qiao-hong, SU Ya-li. Current Status of Dignity of 196 Breast Cancer Women Receiving Chemotherapy and Its Influence Factors [J]. Journal of Nursing, 2020, 27(12): 33-37.
[5] XIAO Xing-mi, SHI Ying, MA Yan, HU Cheng-xi, LU Yan-jun. Family Dignity Intervention for Main Caregivers of Advanced Cancer Patients [J]. Journal of Nursing, 2020, 27(12): 68-72.
[6] . [J]. Journal of Nursing, 2020, 27(10): 43-48.
[7] LU Ting, YING Yan-ping, ZHAO Hui-han, LI Qian, XU Yi, LING Yin. Influence Factors of Handgrip Strength in Patients with Malignant Tumors [J]. Journal of Nursing, 2020, 27(6): 1-4.
[8] . [J]. Journal of Nursing, 2020, 27(6): 23-28.
[9] WU Lei, ZHOU Ji-hong, JIANG Qi-xia. Nursing Difficulties and Clinical Characters of Patients of Stage Ⅳ Stress Injury with Secondary Squamous Cell Carcinoma and Its Interventions: A 2-case Study [J]. Journal of Nursing, 2020, 27(6): 65-68.
[10] ZHANG Dan-ni, ZHU Hui, XIE Chuan-yi, CHEN Xiao-min. Qualitative Research on Caring Experience of Spouse of Breast Cancer Patients: A Meta-analysis [J]. Journal of Nursing, 2020, 27(4): 32-36.
[11] XU Shao-lian, ZANG Mou-hong, TANG Tang, HUO Li-ping, ZHU Zhen-xiang. Implantable Venous Access Port and PICC-related Complications of Cancer Patients Undergoing Chemotherapy: A Meta Analysis [J]. Journal of Nursing, 2020, 27(3): 37-42.
[12] . [J]. Journal of Nursing, 2020, 27(3): 49-53.
[13] . [J]. Journal of Nursing, 2020, 27(1): 19-22.
[14] . [J]. Journal of Nursing, 2019, 26(21): 26-30.
[15] . [J]. Journal of Nursing, 2019, 26(21): 58-62.
Viewed
Full text


Abstract

Cited
  Shared   
[1] XU Hui-na, GUI Yi-hua. PBL Combined with Capacity Enhancement Mode in Blood Purification Technique Training for ICU Nurses[J]. Journal of Nursing, 2020, 27(12): 1 -5 .
[2] . [J]. Journal of Nursing, 2020, 27(12): 10 -13 .
[3] . [J]. Journal of Nursing, 2020, 27(12): 14 -17 .
[4] LU Shu-ying, LIU Ning, Wei Lu-hua, Liang Dong-mei, LI Yan. Best Evidence Summary Regarding Prevention and Management of Postpartum Hemorrhage[J]. Journal of Nursing, 2020, 27(12): 18 -22 .
[5] LIU Xiao-cheng, YING Wen-juan, LIU Zhi-li, ZHENG Rui-hua, XU Nuo, LIU Hui. Best Evidence Summary for Assessment of Sexuality and Intimacy Relationship for Patients with Terminal Stage[J]. Journal of Nursing, 2020, 27(12): 23 -27 .
[6] LIN Hui-jing, NI Ping. Current Status of Attitudes to Life-sustaining Treatment in Citizens and Its Influencing Factors: A 932-case Study[J]. Journal of Nursing, 2020, 27(12): 28 -32 .
[7] ZHU Yi-fan, CHEN Zhi-qian, GUO Qiao-hong, SU Ya-li. Current Status of Dignity of 196 Breast Cancer Women Receiving Chemotherapy and Its Influence Factors[J]. Journal of Nursing, 2020, 27(12): 33 -37 .
[8] . [J]. Journal of Nursing, 2020, 27(12): 38 -41 .
[9] . [J]. Journal of Nursing, 2020, 27(12): 42 -45 .
[10] TIAN Fan-li, LI Hui-ling, DU Mei-lan, JIANG Fang-qin, ZHANG Xin-mei, YIN Xue-qun. Qualitative Study on Emotional Experience of Male Nurses Supporting Wuhan for Fighting COVID-19[J]. Journal of Nursing, 2020, 27(12): 46 -49 .